✦ LIBER ✦

Expression Profiling of the Responses of Pneumocystis carinii to Drug Treatment Using DNA Macroarrays

✍ Scribed by MARGARET S. COLLINS; SANDEEP BANSIL; MELANIE T. CUSHION

Book ID: 109253038
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 235 KB
Volume: 50
Category: Article
ISSN: 1066-5234
DOI: 10.1111/j.1550-7408.2003.tb00646.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterisation of the molecular respon

Characterisation of the molecular responses to xenoestrogens using gene expression profiling

✍ Tracy C. Murphy; George Orphanides 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 225 KB

The use of DNA-microarray technology to

The use of DNA-microarray technology to research the cell cycle and tumour-specific expression profiles

✍ Kerkhoven, Ron M.; Scheijen, Blanca; Bronk, Marieke; Hijmans, Marielle; Kortekaa 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

DNA chip-based expression profile analys

DNA chip-based expression profile analysis indicates involvement of the phosphatidylinositol signaling pathway in multiple plant responses to hormone and abiotic treatments

✍ LIN, Wen Hui; YE, Rui; MA, Hui; XU, Zhi Hong; XUE, Hong Wei 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 764 KB

Genome-wide Analysis of the Expression P

Genome-wide Analysis of the Expression Profile ofSaccharomyces cerevisiaein Response to Treatment with the Plant Isoflavone, Wighteone, as a Potential Antifungal Agent

✍ Hongying Yin; Yongchao Zhao; Yan Zhang; Hongwu Zhang; Lizhen Xu; Zhongmei Zou; W 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 270 KB

Use of DNA microarray technology and gen

Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans

✍ Javier Garaizar; Sonia Brena; Joseba Bikandi; Aitor Rementeria; José Pontón 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

Prediction of the response to peg-interf

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

✍ Bettina E. Hansen; Erik H.C.J. Buster; Ewout W. Steyerberg; Emmanuel Lesaffre; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract Peginterferon (PEG‐IFN) results in HBeAg loss combined with virologic response in only a minority of patients with HBeAg positive chronic hepatitis B. Baseline predictors of response to PEG‐IFN include HBV‐genotype, pre‐treatment HBV DNA levels, and ALT. The aims of this study were to d